| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.3M | -1.4% | +13.3% |
| SG&A Expense | $2.0M | +17.6% | -7.5% |
| Operating Income | -$5.3M | -5.0% | -4.4% |
| Pre-tax Income | -$5.3M | -5.6% | -5.5% |
| Income Tax | $0 | — | — |
| Net Income | -$5.3M | -5.6% | -5.5% |
| EPS (Basic) | -$0.15 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.9M | -43.0% | -67.8% |
| Current Assets | $2.1M | -60.3% | -65.4% |
| Total Assets | $2.9M | -51.9% | -56.8% |
| Current Liabilities | $2.5M | +37.3% | +33.1% |
| Total Liabilities | $2.5M | +37.3% | +33.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.1M | — | — |
| Capital Expenditures | $184K | — | — |
| Investing Cash Flow | -$184K | — | — |
| Financing Cash Flow | $10.7M | — | — |
| Free Cash Flow | -$11.3M | — | — |
| +21.1% |
| EPS (Diluted) | -$0.15 | +0.0% | +21.1% |
| $406K |
| -90.3% |
| -91.5% |